Approach: The research relied extensively on secondary sources, including company websites, investor presentations, press releases, product sites, and Clinicaltrials.gov. Specific keywords were used to systematically identify digital therapeutics (DTx) devices within both the approved and active clinical trials. Estimation of the market size and forecast was conducted by analyzing the prevalence of targeted medical conditions, […]
Evaluation of Novel Subcutaneous Devices and Technologies in Development
Approach: The study employed a comprehensive, multi-dimensional methodology to collect and analyze data on subcutaneous autoinjectors, pen devices, and related drug-device combinations. It began with extensive secondary research, reviewing market reports, reputable news sources, and peer-reviewed publications via PubMed using targeted keywords to gather relevant insights. Simultaneously, clinical trial registries were carefully examined to identify […]
Shortlisting Potential Ivd Manufactures For Acquisition Or Partnership Opportunity
Approach: For the shortlisting of potential in vitro diagnostics (IVD) manufacturers for acquisition or partnership opportunities, the process began with data collection on 320 U.S. and EU-based companies provided by the client. This was supplemented by a secondary search that accessed detailed information on 192 companies through reputable databases such as Biopharmguy, Dun & Bradstreet, […]
Market Opportunities Among Diseases Treated With Immunosuppressants & Steroids
Approach: Data was collected from a comprehensive range of authoritative sources, including treatment guidelines, clinical trials, systematic reviews, meta-analyses, real-world evidence articles, widely respected medical websites (such as Medscape, Medline, and UpToDate), PubMed, and general searches. Approximately 200 autoimmune indications, with potential for immunosuppressant use and including both conditions with and without FDA-approved drugs, were […]
Potential In-licensing Product Candidates
Approach: The process begins by screening products from multiple regulatory and scientific databases (KEGG, PMDA, EMA, FDA) using defined inclusion and exclusion criteria. Selection focuses on products approved in the US or EU between 2016 and 2024, recognized as new molecular or biologic entities not yet approved in Japan, yielding an initial list of 170 […]
Market Share Tracking Of Medical Equipment Using Import Data
Approach: The raw data is initially received in CSV or Excel formats and requires thorough cleaning before it is suitable for analysis. The cleaning process involves identifying and segregating relevant from non-relevant records using specific keywords related to the products of interest. Each import entry is accurately tagged to the corresponding companies and products, with […]
Holter Ecg Device – Regulatory Requirements And Competitor Data Analysis
Approach: The methodology for analyzing the Holter ECG market followed a structured approach focusing on three key areas. Firstly, a comprehensive regulatory analysis was performed, examining device classification, approval processes, quality management systems, and specific regional requirements for Holter ECG devices. Secondly, major market players were identified and profiled, highlighting their headquarters, product portfolios, and […]